| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |